2011 Lung Cancer Research Foundation Annual Grant Program
Ralph Weichselbaum, MD
University of Chicago
Research Project:
Jak/Stat1 axis as the target for radio/chemosensitization of lung cancer
Summary:
This grant expands support of prior LCRF funding to study the potential of inhibitors to a common mutation found in lung cancer as a means of improving the response to radiation and chemotherapy. By decreasing potential resistance to such treatments in patients with this abnormality, it is hoped improved treatment outcomes will occur.